000 | 02911nam a22003137a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20240305193726.0 | ||
008 | 221114b |||||||| |||| 00| 0 eng d | ||
028 | _b Phone: +255 28 298 3384 | ||
028 | _b Fax: +255 28 298 3386 | ||
028 | _b Email: vc@bugando.ac.tz | ||
028 | _b Website: www.bugando.ac.tz | ||
040 | _cDLC | ||
041 | _aEnglish | ||
100 |
_aJ Seni _923416 |
||
245 |
_aPreliminary insights into the occurrence of similar clones of extended‐spectrum beta‐lactamase‐producing bacteria in humans, animals and the environment in Tanzania _bA systematic review and meta‐analysis between 2005 and 2016 |
||
260 |
_aMwanza, Tanzania: _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] & _bZoonoses and public health _c22 August 2017 |
||
300 | _aPages 1-10 | ||
490 | _vZoonoses and public health Volume 65 Issue 1 | ||
520 | _a Summary The emergence and spread of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) are complex and of the public health concern across the globe. This review aimed at assessing the ESBL-PE clones circulating in humans, animals and the environment to provide evidence-based insights for combating ESBL-PE using One Health approach. Systematic search from Medline/PubMed, Google Scholar and African Journals Online was carried out and retrieved nine eligible articles (of 131) based on phenotypic and genotypic detection of ESBL-PE between 2005 and 2016 in Tanzania. Analysis was performed using STATA 11.0 software to delineate the prevalence of ESBL-PE, phenotypic resistance profiles and clones circulating in the three interfaces. The overall prevalence of ESBL-PE in the three interfaces was 22.6% (95% CI: 21.1–24.2) with the predominance of Escherichia coli (E. coli) strains (51.6%). The majority of ESBL-PE were resistant to the commonly used antimicrobials such as trimethoprim–sulfamethoxazole and tetracycline/doxycycline, 38%–55% were resistant to ciprofloxacin and all were sensitive to meropenem/imipenem. ESBL-PE infections were more associated with deaths compared to non-ESBL-PE infections. Strikingly, E. coli ST38, ST131 and ST2852 were found to intersect variably across the three interfaces. The predominant allele, blaCTX-M-15, was found mostly in the conjugative IncF plasmids connoting transmission potential. The high prevalence of ESBL-PE and shared clones across the three interfaces, including the global E. coli ST131 clone, indicates wide and inter-compartmental spread that calls for One Health genomic-driven studies to track the resistome flow. | ||
700 |
_a N Moremi _923339 |
||
700 |
_a M Matee _923633 |
||
700 |
_a F Van der Meer _923634 |
||
700 |
_a R DeVinney _923421 |
||
700 |
_aSE Mshana _923705 |
||
700 |
_aJD D Pitout _945315 |
||
856 | _u https://doi.org/10.1111/zph.12387 | ||
942 |
_2ddc _cVM |
||
999 |
_c19413 _d19413 |